24/7 physician access for vessels at sea.  Call 888.683.7988 or request a consultation →

24/7 line

888.683.7988

DEA asked how to fix the vessel controlled substance rules, then the effort was withdrawn
Maritime medical regulation updates

DEA asked how to fix the vessel controlled substance rules, then the effort was withdrawn

The short version DEA published an advance notice of proposed rulemaking on 18 July 2022, 87 FR 42662, RIN 1117-AB60, docket DEA-598. It proposed no text. It asked four questions
By Discovery Health MD
Medically reviewed by Ann Jarris MD, FACEP
Updated August 2026
8min read
DEA asked how to fix the vessel controlled substance rules, then the effort was withdrawn | Discovery Health MD

The short version

  • DEA published an advance notice of proposed rulemaking on 18 July 2022, 87 FR 42662, RIN 1117-AB60, docket DEA-598.
  • It proposed no text. It asked four questions about how vessels obtain controlled substances.
  • The Department of Justice withdrew it on 11 September 2025 in document 2025-17526, Table 1, and plans no further action.
  • The stated reason is the Federal Government deregulatory initiative following Executive Order 14192 of 31 January 2025.
  • 21 CFR 1301.25 is unchanged. Every obligation an operator had in 2021 still applies.

In July 2022 the DEA published a notice saying, in effect, that the way vessels obtain controlled substances may need rethinking. It asked operators four specific questions. Three years later the Department of Justice withdrew the effort and stated it plans no further action.

So the answer to “have the vessel controlled substance rules changed” is no, and the more useful answer is that the agency responsible for them publicly named the friction points and then stopped. Build to the rule you have.

What DEA actually published, and when it ended

The document was an advance notice of proposed rulemaking, which is the stage before a proposed rule exists. It was published at 87 FR 42662 on 18 July 2022 under RIN 1117-AB60 and docket DEA-598[1].

The stated purpose, verbatim

DEA issued the notice “to obtain information regarding the procurement of controlled substances by a medical officer for emergency kits on board ocean vessels, aircraft, and certain other entities”[1]. It proposed no text. It asked questions.

On 11 September 2025 the Department of Justice published “Department of Justice; Withdrawal of Rulemaking Actions”, document 2025-17526. Table 1, previously published NPRMs and ANPRMs being withdrawn, carries the line: “1117-AB60 | DEA | Providing Controlled Substances to Ocean Vessels, Aircraft, and Other Entities, 87 FR 42662 (July 18, 2022) (ANPRM)”[2].

Date Event Effect on an operator
18 July 2022 ANPRM published, 87 FR 42662, RIN 1117-AB60[1] None. An ANPRM changes no obligation. It collects comment
31 January 2025 Executive Order 14192, the deregulatory initiative cited in the withdrawal[6] None directly, but it is the stated reason the item was dropped
11 September 2025 DOJ withdrawal notice, document 2025-17526, Table 1[2] The modernisation effort ends. The Department plans no further action
Today 21 CFR 1301.25 unchanged[3] Every obligation you had in 2021 you still have

The stated reason for withdrawal is procedural, not substantive: part of the Federal Government deregulatory initiative and ongoing assessments of agency needs, priorities and objectives[2]. Read carefully, that is not a finding that the current framework works.

The four questions DEA asked are the four problems operators actually have

This is the part worth keeping. A regulator does not open an ANPRM about topics nobody complains about, and the four areas DEA put on the table are recognisably the same four that surface in every vessel program review.

What DEA asked about[1] The operational problem behind it
Registration options for entities rather than requiring medical officer involvement Today the permission attaches to a person who must be employed by the owner or operator. Companies would rather register the company[3]
Alternatives where part-time medical officers cause supply delays The employment test is the single most common structural failure in vessel programs, and DEA named it in print
Procedures for masters and first officers purchasing controlled substances The requisition route works but is paperwork-heavy: personal appearance, photo ID, a written requisition, a record of sale in triplicate[3]
Practice on recreational vessels, aircraft and offshore installations The regulation was written for a fleet profile that has changed. The edge cases were never addressed

Question two is the one to sit with. DHMD has argued for years that a consulting physician is not an employee and therefore cannot serve as the medical officer under 1301.25. DEA framed the same issue from the other direction, as a supply-delay problem caused by part-time officers[1]. When the employment test cannot be met, the alternative is set out in the officer and requisition comparison.

What is in force today, unchanged

Nothing in the 2022 notice or the 2025 withdrawal altered a single obligation. Section 1301.25 reads as it did[3].

The medical officer test remains conjunctive: state-licensed physician, employed by the owner or operator, DEA-registered. One registration covers a fleet under a single owner or operator, and a second owner triggers a separate registration or the requisition route[3]. Where no officer is accessible, the master or first officer may requisition, with the record of sale in triplicate and copy 2 retained aboard[3].

The reporting and record obligations are equally unchanged. Two annual reports run on different clocks, the officer’s dated to registration expiry and the master’s per calendar year[3]. Records are kept under part 1304[4], and disposal runs under part 1317 with most routes requiring a registered location ashore[5].

The detail sits across the cluster: 1301.25 explainedrecordkeepingwhat changes by schedulethe two annual reportsdisposal and the inspection checklist.

What a withdrawn notice does and does not mean

Regulatory news travels badly through a fleet. Five readings of this event circulate and only one of them is right.

The reading The position
“The vessel drug rules have been relaxed” No. An ANPRM proposed no text, so nothing was relaxed and nothing was tightened. 1301.25 is word for word what it was[3]
“DEA is no longer interested in vessels” No. Withdrawal was attributed to a government-wide deregulatory initiative, not to any assessment of maritime risk[2]
“Enforcement will ease off” Nothing in either document says so. The inspection posture is unchanged, and the document set an inspector asks for is unchanged. See the inspection checklist
“We can cite the 2022 notice as guidance” Do not. It proposed no text and now has no status. A compliance file quoting a withdrawn ANPRM is weaker than one quoting nothing
“The regime was acknowledged as dated” Yes, and this is the useful reading. DEA opened an inquiry into four specific frictions, then the fix was dropped. The frictions remain yours to manage[1]

The last row is the one to carry into a board meeting. An operator who has been treating the employment test as a technicality now has the regulator’s own words describing it as a supply-delay problem worth studying, and no prospect of relief. The practical routes remain the two in officer or master requisition, and the records behind them in recordkeeping and schedule handling.

Who this actually affects

The ANPRM named ocean vessels, aircraft and certain other entities, and specifically raised recreational vessels and offshore installations as areas of uncertain practice[1]. In practice three groups should read the outcome differently.

Commercial fleets already registered change nothing and simply keep the file current. Operators who deferred a registration decision while waiting for a simpler entity-level route now have their answer, and the answer is that no such route is coming. Fishing and workboat operators, who often sit at the smaller end where a full-time medical officer is hardest to justify, are the group DEA’s second question was really about, and they are the group left with the requisition route as the realistic path. The wider picture for that fleet is in commercial fishing vessel medical requirements and Alaska compliance, and the chest side in the 28.210 rules.

What a sensible operator does with this

  1. Stop waiting. Any program deferring a fix until the rules modernise is now deferring indefinitely. Nothing is pending[2].
  2. Re-test the employment link. It is the friction DEA named and the failure we see most[3]. If the officer is not employed by the owner or operator, the route is the requisition, not a workaround.
  3. Diarise a docket check once a year. A withdrawn ANPRM can be reopened. Annual is proportionate. Monthly is theatre.
  4. Do not cite the 2022 notice as a requirement. It proposed no text and now has no status. Cite the CFR[1].

Point four matters more than it sounds. This project has repeatedly found search results serving instruments that are withdrawn or expired, and a withdrawn ANPRM is exactly the kind of document that gets quoted in a compliance file because it looks official. It is not a rule. It never was. If your program needs building against the rule that is real, the Controlled Substances service exists for that, and consulting reviews the whole picture before an inspection.

Common questions

Did the DEA rules for controlled substances on vessels change?

No. DEA opened an advance notice of proposed rulemaking on 18 July 2022 to gather information[1], and the Department of Justice withdrew it on 11 September 2025[2]21 CFR 1301.25 stands unchanged. See 1301.25 explained.

What was the ANPRM actually asking about?

Procurement of controlled substances by a medical officer for emergency kits on board ocean vessels, aircraft and certain other entities[1]. It raised registration options for entities rather than requiring a medical officer, alternatives where part-time medical officers cause supply delays, master and first officer purchasing procedures, and practice on recreational vessels and offshore installations. Ask how those map to your program.

Why does a withdrawn rulemaking matter to an operator?

Because it tells you the regime is not about to change and that planning around a future fix is not a strategy. The withdrawal notice states the Department plans no further action on the withdrawn items[2]. Build to the rule that exists. Our Controlled Substances service does exactly that.

Why was it withdrawn?

The notice gives a single stated reason: as part of the Federal Government deregulatory initiative and because of ongoing assessments of agency needs, priorities and objectives, following Executive Order 14192 of 31 January 2025[2][6]. It is not a finding that the current rule works well.

Does the employment test still apply to the medical officer?

Yes, in full. The medical officer must be a state-licensed physician, DEA-registered, and employed by the owner or operator[3]. DEA itself flagged part-time officers as a friction point in the 2022 notice[1], and the withdrawal leaves that friction in place. Compare the routes in officer or master requisition.

Should I still expect changes later?

Plan as though not. A withdrawn ANPRM can be reopened, but nothing is pending and no timetable exists[2]. The operationally useful position is to hold a compliant program now and re-check the docket annually rather than defer a fix. See what an audit checks.

What should I do about it this quarter?

Nothing new, and that is the point. Keep the registration or requisition file current, keep both annual reports on their separate clocks, and keep disposal running to a registered location ashore under part 1317[5]. See the two annual reports and disposal.

Not sure your program would survive an inspection?

We provide the DEA-registered medical officer, the registration structure, the records and both annual reports. A physician reviews your fleet and shows you exactly where the gaps are.
Medically reviewed by

Ann Jarris, MD, MBA, FACEP

CEO & Co-Founder · Board-Certified Emergency Physician
Co-founded Discovery Health MD in Seattle in 2016. Every controlled-substances program the company runs is directed by a physician. Meet the physicians →
  1. Providing Controlled Substances to Ocean Vessels, Aircraft, and Other Entities. DEA advance notice of proposed rulemaking, 87 FR 42662, 18 July 2022. RIN 1117-AB60, Docket DEA-598.
  2. Department of Justice; Withdrawal of Rulemaking Actions. 11 September 2025, document 2025-17526. Table 1 lists RIN 1117-AB60 among the previously published NPRMs and ANPRMs being withdrawn.
  3. 21 CFR 1301.25, Registration regarding ocean vessels, aircraft, and other entities. eCFR, read 19 August 2026.
  4. 21 CFR part 1304, Records and reports of registrants. eCFR, read 19 August 2026.
  5. 21 CFR part 1317, Disposal. eCFR, read 19 August 2026.
  6. Executive Order 14192. Issued 31 January 2025. Named in the withdrawal notice as the deregulatory initiative behind it.

Related services: MedChest · Controlled Substances · Consulting · All services

On this page

Would your program pass an inspection?

A physician reviews your logs, requisitions and chain of custody, then shows you the gaps.

24/7 physician line

888.683.7988

Keep reading

The rest of your medical program

Keep reading

Related Article

What a port state inspector actually opens in your medicine chest | Discovery Health MD

What a port state inspector actually opens in your medicine chest

Days from shore planning medical capability by time to definitive care | Discovery Health MD

Days from shore: planning medical capability by time to definitive care

Who is responsible for crew medical compliance, the owner or the DPA | Discovery Health MD

Who is responsible for crew medical compliance, the owner or the DPA?

Scroll to Top